Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Dutasteride Capsules, 0.5 mg. The product is ready for Day 1 launch. The product will be manufactured at the company’s Oral dosage facility at Bangalore and marketed by Strides Shasun in the US Market.
The US market for Dutasteride Capsules is approximately $470 million. The product has gone off patent on November 20, 2015 and Strides Shasun is amongst the first wave of generic players to receive this approval.
Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Pharmaceutical Services & Active Ingredients.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.70 |
| Dr. Reddys Lab | 1236.30 |
| Cipla | 1234.50 |
| Zydus Lifesciences | 938.80 |
| Lupin | 2323.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: